ArticleHarm reduction journal2026
Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study.
Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Accuracy of Patient-Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments: Findings From the Emerging Drugs Network of Australia.Drug and alcohol review · 2026Article
- Discordant Drug Checking Results and Risk Reduction Behaviours: Findings From the ChecKnow Study in France.Drug and alcohol review · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCommunity-based drug checking services have scaled up in response to the unregulated drug toxicity crisis across North America. We sought to assess the relationship between the detection of unexpected active drugs in a drug checking sample and subsequent engagement in risk reduction practices.
methodsWe used data from a cross-sectional study of people who used community-based drug checking services in British Columbia, Canada (March 2020-July 2024). We constructed multivariable logistic regression models to examine the relationship between the detection of unexpected active drugs (i.e., compounds that have psychoactive properties) in samples brought for analysis (using combination Fourier-transform infrared spectroscopy and immunoassay strips) and engagement in subsequent risk reduction practices (e.g., dose reduction, disposal of the drug).
resultsIn total, 447 individuals were included: 174 (38.9%) reported detection of unexpected active drugs in their drug checking sample with the most common being benzodiazepines in expected opioid samples. The most common risk reduction behaviours were to dispose of the drug without using it (n = 24) and taking a smaller dose (n = 11). Through multivariable logistic regression, we found a positive association between detection of unexpected active drugs and engagement in risk reduction practices (adjusted odds ratio = 2.24; 95% confidence interval: 1.30-3.87).
conclusionIndividuals who detected unexpected active drugs in their sample had higher odds of engaging in risk reduction practices. These findings highlight the potential of drug checking services as a harm reduction tool within a suite of services offered to combat the unpredictable and unregulated drug supply.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.